From targets to targeted therapies and molecular profiling in non-small cell lung carcinoma

Author： Thomas A. Rajan A. Lopez-Chavez A. Wang Y. Giaccone G.

ISSN： 0923-7534

Source： Annals of Oncology, Vol.24, Iss.3, 2013-03, pp. : 577-585

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insights into Angiogenesis in Non-Small Cell Lung Cancer: Molecular Mechanisms, Polymorphic Genes, and Targeted Therapies

Recent Patents on Anti-Cancer Drug Discovery, Vol. 7, Iss. 1, 2012-01 ,pp. : 118-131

Bentham Science Publishers

Access to resources Recommend Favorite

How Affordable are Targeted Therapies in Non-Small Cell Lung Cancer?

By Coate Linda

Current Treatment Options in Oncology, Vol. 12, Iss. 1, 2011-03 ,pp. : 1-11

Springer Publishing Company

Access to resources Recommend Favorite

MicroRNAs and Targeted Therapies in Non-small Cell Lung Cancer: Minireview

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 6, 2015-07 ,pp. : 694-700

Bentham Science Publishers

Access to resources Recommend Favorite

Update on targeted therapies for small cell carcinoma of the lung

By Griffiths Richard

Targeted Oncology, Vol. 3, Iss. 3, 2008-07 ,pp. : 205-215

Springer Publishing Company

Access to resources Recommend Favorite

Distinguishing Non-Small Cell Lung Adenocarcinoma Patients from Squamous Cell Carcinoma Patients and Control Individuals Using Serum Profiling

By Hocker James R. Peyton Marvin D. Lerner Megan R. Lightfoot Stan A. Hanas Rushie J. Brackett Daniel J. Hanas Jay S.

Cancer Investigation, Vol. 30, Iss. 2, 2012-02 ,pp. : 180-188

Informa Healthcare

Access to resources Recommend Favorite